Assessment of Psoas Muscle Index in Middle-Aged Type 2 Diabetes Patients: Impact of Insulin Therapy on Sarcopenia

Overview

Journal Tomography

Publisher MDPI

Specialty Radiology

Date 2024 Jul 26

PMID 39058051

Authors

Ismail Taskent

Bunyamin Ece

Sonay Aydin

Affiliations

Soon will be listed here.

Abstract

Objective: Sarcopenia, characterized by progressive skeletal muscle loss, poses significant health risks, including physical impairment and mortality. The relationship between sarcopenia and insulin resistance suggests insulin therapy's potential in preserving muscle mass, particularly in Type 2 diabetes mellitus (T2DM) patients. This study aims to evaluate the Psoas Muscle Index (PMI) via computed tomography (CT) in middle-aged T2DM patients on insulin therapy versus oral antidiabetic drugs (OAD) and controls.

Methods: This retrospective study included 107 middle-aged T2DM patients undergoing non-contrast CT scans and 58 age-matched controls. CT images were analyzed to calculate PMI. Statistical analysis included Chi-square tests, independent samples -tests, Mann-Whitney U tests, and correlation analyses.

Results: Insulin-treated patients exhibited higher PMI than OAD users ( < 0.001), while OAD users had lower PMI than controls ( < 0.001). No significant difference was found between insulin-treated patients and controls ( = 0.616). Negative correlations were observed between T2DM duration/age and PMI across all groups, with a positive correlation between T2DM duration and BMI observed in the OAD group.

Conclusions: Insulin therapy in T2DM patients, regardless of age or disease duration, positively impacts muscle mass, highlighting its potential in preserving muscular health and advocating for tailored treatment strategies in T2DM management.

References

Lee C, Boyko E, Barrett-Connor E, Miljkovic I, Hoffman A, Everson-Rose S . Insulin sensitizers may attenuate lean mass loss in older men with diabetes. Diabetes Care. 2011; 34(11):2381-6. PMC: 3198278. DOI: 10.2337/dc11-1032. View

Derstine B, Holcombe S, Goulson R, Ross B, Wang N, Sullivan J . Quantifying Sarcopenia Reference Values Using Lumbar and Thoracic Muscle Areas in a Healthy Population. J Nutr Health Aging. 2018; 21(10):180-185. DOI: 10.1007/s12603-017-0983-3. View

Baumgartner R, Koehler K, Gallagher D, Romero L, Heymsfield S, Ross R . Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147(8):755-63. DOI: 10.1093/oxfordjournals.aje.a009520. View

Gomez-Perez S, Haus J, Sheean P, Patel B, Mar W, Chaudhry V . Measuring Abdominal Circumference and Skeletal Muscle From a Single Cross-Sectional Computed Tomography Image: A Step-by-Step Guide for Clinicians Using National Institutes of Health ImageJ. JPEN J Parenter Enteral Nutr. 2015; 40(3):308-18. PMC: 4767633. DOI: 10.1177/0148607115604149. View

Fukuoka Y, Narita T, Fujita H, Morii T, Sato T, Sassa M . Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients. J Diabetes Investig. 2018; 10(2):322-330. PMC: 6400206. DOI: 10.1111/jdi.12908. View

Mensink M, Hesselink M, Russell A, Schaart G, Sels J, Schrauwen P . Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. Int J Obes (Lond). 2007; 31(8):1302-10. DOI: 10.1038/sj.ijo.0803567. View

Kalyani R, Tra Y, Yeh H, Egan J, Ferrucci L, Brancati F . Quadriceps strength, quadriceps power, and gait speed in older U.S. adults with diabetes mellitus: results from the National Health and Nutrition Examination Survey, 1999-2002. J Am Geriatr Soc. 2013; 61(5):769-75. PMC: 3725774. DOI: 10.1111/jgs.12204. View

Sanada K, Miyachi M, Tanimoto M, Yamamoto K, Murakami H, Okumura S . A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol. 2010; 110(1):57-65. DOI: 10.1007/s00421-010-1473-z. View

Shishikura K, Tanimoto K, Sakai S, Tanimoto Y, Terasaki J, Hanafusa T . Association between skeletal muscle mass and insulin secretion in patients with type 2 diabetes mellitus. Endocr J. 2014; 61(3):281-7. DOI: 10.1507/endocrj.ej13-0375. View

10.

Srikanthan P, Hevener A, Karlamangla A . Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One. 2012; 5(5):e10805. PMC: 3279294. DOI: 10.1371/journal.pone.0010805. View

11.

Kim J, Wilson J, Lee S . Dietary implications on mechanisms of sarcopenia: roles of protein, amino acids and antioxidants. J Nutr Biochem. 2009; 21(1):1-13. DOI: 10.1016/j.jnutbio.2009.06.014. View

12.

Park S, Goodpaster B, Strotmeyer E, Kuller L, Broudeau R, Kammerer C . Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007; 30(6):1507-12. DOI: 10.2337/dc06-2537. View

13.

Fujita S, Glynn E, Timmerman K, Rasmussen B, Volpi E . Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism. Diabetologia. 2009; 52(9):1889-98. PMC: 2843438. DOI: 10.1007/s00125-009-1430-8. View

14.

Mavros Y, Kay S, Anderberg K, Baker M, Wang Y, Zhao R . Changes in insulin resistance and HbA1c are related to exercise-mediated changes in body composition in older adults with type 2 diabetes: interim outcomes from the GREAT2DO trial. Diabetes Care. 2013; 36(8):2372-9. PMC: 3714491. DOI: 10.2337/dc12-2196. View

15.

Mesinovic J, Zengin A, de Courten B, Ebeling P, Scott D . Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metab Syndr Obes. 2019; 12:1057-1072. PMC: 6630094. DOI: 10.2147/DMSO.S186600. View

16.

Ferrari U, Then C, Rottenkolber M, Selte C, Seissler J, Conzade R . Longitudinal association of type 2 diabetes and insulin therapy with muscle parameters in the KORA-Age study. Acta Diabetol. 2020; 57(9):1057-1063. DOI: 10.1007/s00592-020-01523-7. View

17.

Tanaka K, Kanazawa I, Sugimoto T . Reduction in Endogenous Insulin Secretion is a Risk Factor of Sarcopenia in Men with Type 2 Diabetes Mellitus. Calcif Tissue Int. 2015; 97(4):385-90. DOI: 10.1007/s00223-015-9990-8. View

18.

Zannoni S, Albano D, Jannone M, Messina C, Sconfienza L . Correlation between muscle mass and quality around the hip and of psoas muscles at L3 level using unenhanced CT scans. Skeletal Radiol. 2020; 49(10):1649-1655. DOI: 10.1007/s00256-020-03475-z. View

19.

Cruz-Jentoft A, Baeyens J, Bauer J, Boirie Y, Cederholm T, Landi F . Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39(4):412-23. PMC: 2886201. DOI: 10.1093/ageing/afq034. View

20.

Tandon P, Ney M, Irwin I, Ma M, Gramlich L, Bain V . Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl. 2012; 18(10):1209-16. DOI: 10.1002/lt.23495. View